Core Scientific’s Largest Active Shareholder to Vote Against CoreWeave Acquisition
Key Takeaways: Two Seas Capital opposes CoreWeave’s proposed acquisition of Core Scientific, citing valuation and deal structure concerns. The deal’s all-stock nature raises broader questions about shareholder protections amid volatile AI infrastructure valuations. Institutional investor resistance may indicate shifting expectations for governance and transparency in high-growth infrastructure sectors. Two Seas Capital, which holds a 6.3%…
